68 related articles for article (PubMed ID: 3877774)
1. Radioimmunoassay for urinary amyloid P component.
Maury CP; Teppo AM
J Lab Clin Med; 1985 Dec; 106(6):619-23. PubMed ID: 3877774
[TBL] [Abstract][Full Text] [Related]
2. Is the urinary protein excretion pattern compatible with renal morphological findings in renal amyloidosis?
Erdoğan O; Demircin G; Bülbül M; Memiş L; Oner A
Ren Fail; 2009; 31(1):13-7. PubMed ID: 19142804
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of amyloid fibrils in urinary sediment.
Derosena R; Koss MN; Pirani CL
N Engl J Med; 1975 Nov; 293(22):1131-3. PubMed ID: 1186775
[No Abstract] [Full Text] [Related]
5. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
Hind CR; Tennent GA; Evans DJ; Pepys MB
J Pathol; 1983 Feb; 139(2):159-66. PubMed ID: 6338184
[TBL] [Abstract][Full Text] [Related]
6. Amyloid fibrils in urinary sediment. Heroin addiction with renal amyloidosis.
Brus I; Steiner G; Maceda A; Lejano R
N Y State J Med; 1979 Apr; 79(5):768-71. PubMed ID: 286178
[No Abstract] [Full Text] [Related]
7. Serum amyloid P-component levels in amyloidosis, connective tissue diseases, infection, and malignancy as compared to normal serum.
Skinner M; Vaitukaitis JL; Cohen AS; Benson MD
J Lab Clin Med; 1979 Oct; 94(4):633-8. PubMed ID: 479670
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid P-component as a marker of liver disease.
Levo Y; Shalit M; Tur-Kaspa R
Am J Gastroenterol; 1982 Jun; 77(6):427-30. PubMed ID: 7091128
[TBL] [Abstract][Full Text] [Related]
9. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay measurement of thromboxane B2 in human plasma and urine.
Hornych A; Krief C; Bariety J
Prostaglandins Leukot Med; 1982 May; 8(5):467-80. PubMed ID: 6954551
[TBL] [Abstract][Full Text] [Related]
11. Excretion of Tamm-Horsfall glycoprotein in renal disease.
Lynn KL; Marshall RD
Clin Nephrol; 1984 Nov; 22(5):253-7. PubMed ID: 6518675
[TBL] [Abstract][Full Text] [Related]
12. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
Strachan AF; Johnson PM
J Clin Lab Immunol; 1982 Sep; 8(3):153-6. PubMed ID: 6813503
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
14. Circadian rhythm of serum erythropoietin in multiple myeloma.
Pasqualetti P; Collacciani A; Casale R
Am J Hematol; 1996 Sep; 53(1):40-2. PubMed ID: 8813096
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
[TBL] [Abstract][Full Text] [Related]
16. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
Transplantation; 2003 Jun; 75(12):2113-9. PubMed ID: 12829921
[TBL] [Abstract][Full Text] [Related]
17. Urinary immunoreactive gastrin in normal subjects.
Du B; Zhang J; Eng J; Yalow RS
Horm Metab Res; 1984 Mar; 16(3):132-5. PubMed ID: 6714925
[TBL] [Abstract][Full Text] [Related]
18. [Determination of amyloid P component in blood by an immunoenzyme method].
Bannikova EM; Nasonov EL; Tishchenko VA; Nagornaia LV; Sura VV
Biull Eksp Biol Med; 1989 Jul; 108(7):99-101. PubMed ID: 2804308
[TBL] [Abstract][Full Text] [Related]
19. Renal involvement in systemic amyloidosis.
Browning M; Banks R; Tribe C; Bacon P; Hollingworth P; Kingswood C; Poulding J; Harrison P; Mackenzie JC
Proc Eur Dial Transplant Assoc; 1983; 20():595-602. PubMed ID: 6657678
[TBL] [Abstract][Full Text] [Related]
20. Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria.
Falck HM; Törnroth T; Wegelius O
Clin Nephrol; 1983 Mar; 19(3):137-42. PubMed ID: 6839564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
